GlassScriptPhysician profile
Monica A Bowen
NPI 1366768756
$750.94
in general payments reported to CMS, 2019-2025
13 companies · $35.38 in 2025
The $35.38 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $296 · 2021: $41.27 · 2022: $99.16 · 2023: $70.88 · 2024: $68.34 · 2025: $35.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $174.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $115.03 | 2020-2025 | Camzyos, Eliquis |
| Pfizer INC. | $110.93 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $91.91 | 2019 | |
| Janssen Pharmaceuticals, INC | $84.36 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $78.60 | 2020 | |
| Novo Nordisk INC | $77.43 | 2019-2024 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.88 | 2022 | |
| Merck Sharp & Dohme LLC | $33.71 | 2020 | |
| Abbvie INC. | $27.36 | 2023 | Teflaro |
| Pharmacyclics LLC, An Abbvie Company | $27.06 | 2023 | Imbruvica |
| Portola Pharmaceuticals, LLC | $24.98 | 2020 | |
| Inspire Medical Systems, INC. | $17.86 | 2025 | Inspire |
| Mylan Specialty L.P. | $12.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Bowen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.